Clinical trial
An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients…
NCT00280397 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00280397 |
|---|---|
| Title | An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors |
| Official title | An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer: Solid Tumors |
| Intervention type | Drug |
| Interventions | E7080 |
| Enrollment | 27 |
| Start date | Jan 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jan 23, 2006 |
| Last update posted | Oct 7, 2016 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: